14 results found.

Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Ne Clinical Trial using questionnaire administration; cognitive assessment; psychosocial assessment and care; quality-of-life assessment

Children's Oncology Group - Recruiting 1 Month to 21 years.
- Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children With Cancer.
questionnaire administration; cognitive assessment; psychosocial assessment and care; quality-of-life assessment

Mesothelioma Clinical Trial using Pemetrexed + Cisplatin or Carboplatin AUC=5 Pleurectomy/decortication (if feasible) Intensity Modulated Radiation Therapy

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Phase II Toxicity Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma..
Pemetrexed + Cisplatin or Carboplatin AUC=5 Pleurectomy/decortication (if feasible) Intensity Modulated Radiation Therapy

Prostate Cancer, or Radiation Toxicity Clinical Trial using medical chart review; questionnaire administration; quality-of-life assessment; brachytherapy; radiation therapy

University of California, San Francisco - Recruiting N/A or older.
- Pre-Operative Gleason Score and PSA and Clinical Stage in Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer.
medical chart review; questionnaire administration; quality-of-life assessment; brachytherapy; radiation therapy

Endometrial Cancer, Gastrointestinal Complications, Radiation Tox Clinical Trial using 45 Gy/25 fractions

ICORG- All Ireland Cooperative Oncology Research Group - Recruiting 18 years or older.
- Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer.
45 Gy/25 fractions

Solid Tumors With Oligometastatic Spread Clinical Trial using Radiation: 50Gy in 5 fr (max) to 25 Gy in 5 fr (min). Dose adapted to deliver the highest dose level while respecting normal tissue tolerance

University Health Network, Toronto - Recruiting 18 years or older.
- A Phase II Study on the Toxicity and Efficacy of a Normal Tissue Tolerance Adapted, 5 Fraction Stereotactic Body Radiation Therapy (SBRT) Regimen, for Extra-Cranial Oligometastases.
Radiation: 50Gy in 5 fr (max) to 25 Gy in 5 fr (min). Dose adapted to deliver the highest dose level while respecting normal tissue tolerance

Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment Clinical Trial using hypofractionated radiation therapy

Radiation Therapy Oncology Group - Recruiting 18 years or older.
- A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer.
hypofractionated radiation therapy

Head and Neck Cancer, Long-term Effects Secondary to Cancer Thera Clinical Trial using Acupuncture

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- A Phase III Prospective Randomized Trial of Acupuncture for Treatment of Radiation-Induced Xerostomia in Patients With Head and Neck Cancer.
Acupuncture

Stage IA Uterine Sarcoma, Stage IB Uterine Sarcoma, Stage IC Uter Clinical Trial using gemcitabine hydrochloride; docetaxel; brachytherapy; intensity-modulated radiation therapy; external beam radiation therapy; laboratory biomarker analysis

Albert Einstein College of Medicine of Yeshiva University - Recruiting 18 years or older.
- A Pilot Safety and Toxicity Trial of Adjuvant Chemotherapy With Gemcitabine and Docetaxel and Radiation Therapy for Completely Resected Uterine Leiomyosarcoma.
gemcitabine hydrochloride; docetaxel; brachytherapy; intensity-modulated radiation therapy; external beam radiation therapy; laboratory biomarker analysis

Breast Cancer, or Brain Metastasis Clinical Trial using Radiation therapy Brain metastasis in breast cancer

Institut Paoli-Calmettes - Recruiting 18 years or older.
- Double-blind Randomized Multicenter Phase III Study Evaluation of the Efficacy of Hippocampal Avoidance on the Cognitive Toxicity of Whole-brain Radiation Therapy After Surgical Resection of Single Brain Metastasis of Breast Cancer..
Radiation therapy Brain metastasis in breast cancer

Pancreatic Cancer Clinical Trial using GVAX pancreatic cancer vaccine; cyclophosphamide

Sidney Kimmel Comprehensive Cancer Center - Recruiting 18 years or older.
- A Randomized Three-arm Neoadjuvant and Adjuvant Feasibility and Toxicity Study of a GM-CSF Secreting Allogeneic Pancreatic Cancer Vaccine Administered Either Alone or in Combination With Either a Single Intravenous Dose or Daily Metronomic Oral Doses of Cyclophosphamide for the Treatment of Patients With Surgically Resected Adenocarcinoma of the Pancreas.
GVAX pancreatic cancer vaccine; cyclophosphamide

Chemotherapeutic Agent Toxicity, Lymphoma, Mucositis, or Neurotox Clinical Trial using glucarpidase; leucovorin calcium; methotrexate; laboratory biomarker analysis; quality-of-life assessment; radiation therapy

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Phase I Trial of Escalating High Dose Methotrexate Supported by Glucarpidase to Treat Patients With Primary Central Nervous Lymphoma (PCNSL).
glucarpidase; leucovorin calcium; methotrexate; laboratory biomarker analysis; quality-of-life assessment; radiation therapy

Rectal Cancer, Gastric Cancer, Bone Marrow Toxicity, or Adverse E Clinical Trial using Bone Marrow-sparing Intensity-Modulated Radiotherapy

Chinese Academy of Medical Sciences - Recruiting 18 years to 75 years.
- Phase II Clinical Trial: The Effect of Bone Marrow-sparing Intensity-Modulated Radiotherapy (BMS-IMRT) on Reduction Acute Hematologic Toxicity in Gastric and Rectal Cancer Patients Treated With Concurrent Chemotherapy and IMRT.
Bone Marrow-sparing Intensity-Modulated Radiotherapy

Abnormalities, Radiation-Induced Clinical Trial

University Health Network, Toronto - Recruiting 18 years or older.
- Optical Coherence Tomography for Monitoring Late Oral Radiation Toxicity After Radiotherapy of Head and Neck Cancer Patients.

Head and Neck Cancer, Ototoxicity, or Radiation Toxicity Clinical Trial using adjuvant therapy; assessment of therapy complications; quality-of-life assessment; 3-dimensional conformal radiation therapy; intensity-modulated radiation therapy

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Multicenter Randomized Study of Cochlear Sparing Intensity Modulated Radiotherapy Versus Conventional Radiotherapy in Patients With Parotid Tumors.
adjuvant therapy; assessment of therapy complications; quality-of-life assessment; 3-dimensional conformal radiation therapy; intensity-modulated radiation therapy